The metabolic shift to be more OXPHOS dependent with an advantage of enhanced tumorigenic growth and stemness in advanced growth of prostate cancer is mediated by the upstream transcriptional regulation by ERRα that linking the upregulation of ACO2 in TCA cycle and the downregulation of ZIP1 leading to the loss of intracellular Zn. The gene discussed is ESRRA; the disease is prostate cancer.